Literature DB >> 12100032

Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia.

R Schubert1, J Reichenbach, S Zielen.   

Abstract

Chronic sinopulmonary infections that are associated with immunodeficiency are one of the leading causes of death in the multi-systemic disease ataxia telangiectasia (AT). Immunological investigations of AT patients revealed a broad spectrum of defects in the humoral and the cellular immune system. Based on their important role in host defence the aim of our study was an extensive analysis of cell distribution and function of CD4+ and CD8+ T lymphocytes and NK cells. We found that naive (CD45RA+) CD4+ lymphocytes, as well as CD8+/CD45RA+ lymphocytes, are decreased, whereas NK cells (CD3-/CD16+CD56+) are significantly elevated in AT patients. In our culture system proliferation and cytokine production was normal in purified memory (CD45RO+) lymphocytes after stimulation with phorbol-12,13-dibutyrate (PBu2) and after PHA activation, indicating that differences in proliferation and cytokine production are due solely to reduced numbers of CD45RA+ lymphocytes. However, activation, and especially intracellular interferon production of AT lymphocytes, seem to follow different kinetics compared to controls. In contrast to polyclonal activation, stimulation via the T cell receptor results consistently in a reduced immune response. Taken together, our results suggest that deficiency of immunocompetent cells and an intrinsic immune activation defect are responsible for the immunodeficiency in AT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100032      PMCID: PMC1906431          DOI: 10.1046/j.1365-2249.2002.01830.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  The many substrates and functions of ATM.

Authors:  M B Kastan; D S Lim
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

Review 2.  Speculations on ataxia-telangiectasia: defective regulation of the immunoglobulin gene superfamily.

Authors:  R D Peterson; J D Funkhouser
Journal:  Immunol Today       Date:  1989-09

3.  NK phenotypic markers and IL2 response in NK cells from elderly people.

Authors:  F Borrego; M C Alonso; M D Galiani; J Carracedo; R Ramirez; B Ostos; J Peña; R Solana
Journal:  Exp Gerontol       Date:  1999-04       Impact factor: 4.032

Review 4.  Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.

Authors:  R A Gatti; E Boder; H V Vinters; R S Sparkes; A Norman; K Lange
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

Review 5.  Cancer in ataxia-telangiectasia patients.

Authors:  F Hecht; B K Hecht
Journal:  Cancer Genet Cytogenet       Date:  1990-05

6.  Defective interferon-gamma production in ataxia-telangiectasia.

Authors:  R Paganelli; M R Capobianchi; P M Matricardi; L Cioè; R Seminara; F Dianzani; F Aiuti
Journal:  Clin Immunol Immunopathol       Date:  1984-09

7.  Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.

Authors:  Y Xu; T Ashley; E E Brainerd; R T Bronson; M S Meyn; D Baltimore
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

Review 8.  Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction.

Authors:  M F Lavin; Y Shiloh
Journal:  Curr Opin Immunol       Date:  1996-08       Impact factor: 7.486

9.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice.

Authors:  P R Borghesani; F W Alt; A Bottaro; L Davidson; S Aksoy; G A Rathbun; T M Roberts; W Swat; R A Segal; Y Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  21 in total

1.  Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.

Authors:  Anthony D D'Souza; Ian A Parish; Sharen E McKay; Susan M Kaech; Gerald S Shadel
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

2.  Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients.

Authors:  C Chopra; G Davies; M Taylor; M Anderson; S Bainbridge; P Tighe; E M McDermott
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

3.  Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia.

Authors:  A Stray-Pedersen; I S Aaberge; A Früh; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia.

Authors:  J Reichenbach; R Schubert; J Feinberg; O Beck; M Rosewich; M A Rose; S Zielen
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

5.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

6.  Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.

Authors:  E R Staples; E M McDermott; A Reiman; P J Byrd; S Ritchie; A M R Taylor; E G Davies
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

7.  Safety and efficacy of treatment using interleukin-2 in a patient with idiopathic CD4(+) lymphopenia and Mycobacterium avium-intracellulare.

Authors:  T Trojan; R Collins; D A Khan
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

8.  Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.

Authors:  Rachel Warren; William Domm; Min Yee; Andrew Campbell; Jane Malone; Terry Wright; Margot Mayer-Pröschel; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

9.  Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis.

Authors:  C J Harbort; Paulo Vitor Soeiro-Pereira; Horst von Bernuth; Angela M Kaindl; Beatriz Tavares Costa-Carvalho; Antonio Condino-Neto; Janine Reichenbach; Joachim Roesler; Arturo Zychlinsky; Borko Amulic
Journal:  Blood       Date:  2015-10-21       Impact factor: 22.113

10.  Survival and Functional Immune Reconstitution After Haploidentical Stem Cell Transplantation in Atm-Deficient Mice.

Authors:  Ruth Pia Duecker; Lucia Gronau; Patrick C Baer; Stefan Zielen; Ralf Schubert
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.